ProQR Therapeutics (PRQR) Shares Outstanding (2013 - 2026)

ProQR Therapeutics has reported Shares Outstanding (Entity) for 15 years, with the latest figure at $107.7 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.0% year-over-year to $107.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107.7 million (changed 0.0% YoY) and the FY2025 annual result came in at $105.4 million, up 22.39% from the prior year.
• Shares Outstanding (Entity) climbed to $107.7 million in Q1 2026 per PRQR's latest filing, from $105.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $107.7 million in Q1 2025 and troughed at $74.9 million in Q1 2022.
• A 5-year average of $89.1 million and a median of $84.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) soared 36.54% in 2022, then changed 0.0% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $80.8 million in 2022, then advanced by 0.67% to $81.4 million in 2023, then climbed by 5.82% to $86.1 million in 2024, then gained by 22.39% to $105.4 million in 2025, then increased by 2.23% to $107.7 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $107.7 million, $105.4 million, and $107.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.